Iannis E. Adamopoulos

Stimulation of osteoclast formation by inflammatory synovial fluid.

In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line.

Macrophage-mediated biodegradation of poly(DL-lactide-co-glycolide) in vitro.

Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.

Hepatocyte growth factor can substitute for M-CSF to support osteoclastogenesis.

Immune regulation of bone loss by Th17 cells.

Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors.

Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis.

Structural, cellular, and molecular evaluation of bone erosion in experimental models of rheumatoid arthritis: assessment by μCT, histology, and serum biomarkers.

Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.

IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass.

Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.

The emerging role of Interleukin 27 in inflammatory arthritis and bone destruction.

The implication of vitamin D and autoimmunity: a comprehensive review.

A mutation in mouse Pak1ip1 causes orofacial clefting while human PAK1IP1 maps to 6p24 translocation breaking points associated with orofacial clefting.

NKG2C, HLA-E and their association with psoriasis.

The IL-23/IL-17 axis in psoriatic arthritis.

IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis.